CNY:PA:PA-HSBC MSCI China UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 6.75

Change

+0.14 (+2.06)%

Market Cap

USD 0.62B

Volume

0.03M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

N/A

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+3.50 (+0.60%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.55 (+0.37%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

+0.23 (+0.63%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.48 (+0.58%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+5.00 (+0.98%)

USD 8.92B
WLD:PA Lyxor UCITS MSCI World D-EUR

+2.01 (+0.55%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

+0.28 (+0.48%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.12 (+0.59%)

USD 6.91B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+0.91 (+0.55%)

USD 5.17B

ETFs Containing CNY:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.00% 85% B 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.00% 85% B 77% C+
Trailing 12 Months  
Capital Gain 38.55% 93% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.55% 93% A 92% A
Trailing 5 Years  
Capital Gain -15.81% 11% F 34% F
Dividend Return 3.93% 6% D- 10% F
Total Return -11.89% 11% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain -7.56% 5% F 20% F
Dividend Return N/A 54% F 50% F
Total Return N/A 18% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) N/A 8% B- 47% F
Risk Adjusted Return N/A 1% F 49% F
Market Capitalization 0.62B 69% C- 72% C

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.